HORMONAL PROFILES IN SUCCESSFUL AND UNSUCCESSFUL IMPLANTATION IN IVF-ET AFTER COMBINED GNRH AGONIST GONADOTROPIN TREATMENT FOR SUPEROVULATION AND HCG LUTEAL SUPPORT

被引：14

作者：

BALASCH, J

CREUS, M

FABREGUES, F

CARMONA, F

CASAMITJANA, R

PENARRUBIA, J

RIVERA, F

VANRELL, JA

机构：

[1] Department of Obstetrics and Gynecology, Barcelona

[2] Hormonal Laboratory, University of Barcelona, Hospital Clínic i Provincial, Barcelona

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 1995年 / 9卷 / 01期

关键词：

ESTRADIOL; GNRH ANALOG; HCG SUPPORT; IMPLANTATION; IVF-ET; LUTEAL PHASE; PROGESTERONE; PROLACTIN;

D O I：

10.3109/09513599509160191

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The luteal phase of in vitro fertilization-embryo transfer (IVF-ET) cycles has come under great scrutiny as the cause for the discrepancy between fertilization rates (> 70%) and pregnancy rates (around 20%) in most IVF programs is sought. The effects of the various stimulation protocols on the subsequent hormonal events of the luteal phase are both important and controversial but information regarding cycles where ovarian stimulation has been carried out with gonadotropins under pituitary suppression is scanty. The effect of high levels of estrogen in the late follicular phase and around the time of implantation is a matter of concern. As combined gonadotropin-releasing hormone analog (GnRH-a) gonadotropin treatment for superovulation is associated with supraphysiological ovarian steroid levels, both in the follicular and luteal phase of IVF cycles, we compared preovulatory (estradiol), midluteal (estradiol, progesterone and prolactin) and late luteal (estradiol and progesterone) hormone levels in on-going pregnancies, abortions and non-conception cycles in 222 patients accomplishing their first IVF-ET attempt who received such ovarian stimulation therapy. For both successful and unsuccessful implantation cycles, estradiol on the day of human chorionic gonadotropin (hCG) administration correlated positively with progesterone and estradiol levels and negatively with the progesterone/estradiol ratio in the midluteal phase. Mean peak follicular estradiol, midluteal estradiol and progesterone levels, mean mid- and late luteal progesterone/estradiol ratio, and mean midluteal prolactin concentration, were similar in the three groups studied. The mean late luteal estradiol and progesterone in the on-going pregnancy group were significantly higher than in non-conception cycles (p < 0.005 and p < 0.001, respectively) as a reflection of trophoblastic hCG production. Forty-eight patients (21.6%) had hyperprolactinemia. Estradiol and progesterone at around the time of implantation were significantly higher (p < 0.001) in the hyperprolactinemic group but the progesterone/estradiol ratio, conception rate and pregnancy outcome were similar in patients with normal prolactin levels and those having hyperprolactinemia. It is concluded that combined GnRH-a/gonadotropin treatment for superovulation in IVF adversely affects neither the hormonal milieu of the luteal phase nor implantation, provided that hCG luteal phase support is given.

引用

页码：51 / 58

页数：8

共 27 条

[11]

Zacur H.A., Foster G.V., Hyper-prolactinemia and prolactin-secreting adenomas, Decision Making in Reproductive Endocrinology, pp. 151-155, (1993)

[12]

Howles C.M., Macnamee M.C., Edwards R.G., Follicular development and early luteal function of conception and non-conception cycles after human in vitro fertilization: endocrine correlates, Hum. Reprod, 2, pp. 17-21, (1987)

[13]

Smitz J., Devroey P., Braeckmans P., Camus M., Khan I., Staessen C., Van Waesberghe L., Wisanto A., Van Steirteghem A.C., Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and hMG, Hum. Reprod, 2, pp. 309-314, (1987)

[14]

Smitz J., Devroey P., Camus M., Deschacht J., Khan I., Staessen C., Van Waesberghe L.V., Wisanto A., Van Steirteghem A.C., The luteal phase and early pregnancy after combined GnRH-agonist/hMG treatment for super-ovulation in IVF or GIFT, Hum. Reprod, 3, pp. 585-590, (1988)

[15]

Smitz J., Erard P., Camus M., Devroey P., Tournaye H., Wisanto A., Van Steirteghem A.C., Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and hMG in a desensitization or flare-up protocol, Hum. Reprod, 7, pp. 1225-1229, (1992)

[16]

Steptoe P.C., Edwards R.G., Purdy J.M., Clinical aspects of pregnancies established with cleaving embryos grown in vitro, Br. J. Obstet. Gynaecol, 87, pp. 757-768, (1980)

[17]

Graf M.J., Reyniak J.V., Battle-Mutter P., Laufer N., Histologic evaluation of the luteal phase in women following follicle aspiration for oocyte retrieval, Fertil. Steril, 49, pp. 616-619, (1988)

[18]

Gidley-Baird A.A., O'Neill C., Sinosich M.J., Porter R.N., Pike I.L., Saunders D.M., Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progesterone/estrogen ratios in humans and mice, Fertil. Steril, 45, pp. 69-74, (1986)

[19]

Hutchinson-Williams K.A., DeCherney A.H., Lavy G., Diamond M.P., Naftolin F., Lunenfeld B., Luteal rescue in in vitro fertilization-embryo transfer, Fertil. Steril, 53, pp. 495-501, (1990)

[20]

Daya S., Efficacy of progesterone support in the luteal phase following in vitro fertilization and embryo transfer: meta-analysis of clinical trails, Hum. Reprod, 3, pp. 731-734, (1988)

← 1 2 3 →